Page 198 - AACN Essentials of Critical-Care Nursing Pocket Handbook, Second Edition

N-acetyl procainamide is active metabolite; hepatitis; rash QT prolongation; increased Dosage adjustment should be made when 185

Comments lupus-like syndrome; rash; agranulocytosis; QT prolongation Therapeutic range: PA 4-10 mg/L, NAPA 10-20 mg/L Diarrhea, nausea, headache dizziness; hypersensitivity reactions including thrombocytopenia; hemolysis; fever digoxin leve

Loading dose: (IV) 15 mg/kg at 25-50 mg/min PO q12h
Dosage Maintenance dose: (IV) 2-5 mg/min Quinidine sulfate: 200-300 mg PO q6h Quinidine sulfate: 324-648 mg PO q8h 100-300 mg PO q6h; SR: 100-300 mg

Antiarrhythmic Agents Indications Ventricular ectopy; conversion of atrial fibrillation and atrial flutter; WPW Ventricular ectopy; conversion of atrial fibrillation and atrial flutter; WPW Ventricular ectopy; conversion of atrial fibrillation an

Agents Procainamide Disopyramide
7.4 Class IA Quinidine